What Will Going Public Look Like Post Pandemic?
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Marcio Souza, CEO of Praxis Precision Medicines, a clinical stage biopharma, and David Perry, cofounder and chairman of Better Therapeutics, share thoughts on what the future of taking a company public could/should look like.
This website uses cookies to ensure you get the best experience on our website. Learn more